Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030

Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030


The Molecular Biology Enzymes & Kits & Reagents Market size was estimated at USD 19.14 billion in 2023 and expected to reach USD 21.35 billion in 2024, at a CAGR 11.88% to reach USD 42.02 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Molecular Biology Enzymes & Kits & Reagents Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Molecular Biology Enzymes & Kits & Reagents Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Molecular Biology Enzymes & Kits & Reagents Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Agilent Technologies, Inc., Bio Basic Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fortis Life Sciences, Illumina, Inc., Jena Bioscience GmbH, Krishgen Biosystems, LGC Limited, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Molecular Biology Resources, Inc., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Rockland Immunochemicals, Inc., Sartorius AG, Takara Holdings Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Molecular Biology Enzymes & Kits & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Enzymes
DNA Polymerases
Ligases
Restriction Enzymes

Kits
DNA Sequencing Kits
PCR Kits
RNA Extraction Kits

Reagents
Buffers
Dyes
Nucleotides
Primers
Stains
Application

Drug Discovery & Development

Epigenetics

Polymerase Chain Reaction

Sequencing
End-User

Academic & Research institutions

Diagnostic Centers

Hospitals

Pharma & Biotech Companies
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Molecular Biology Enzymes & Kits & Reagents Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Molecular Biology Enzymes & Kits & Reagents Market?
3. What are the technology trends and regulatory frameworks in the Molecular Biology Enzymes & Kits & Reagents Market?
4. What is the market share of the leading vendors in the Molecular Biology Enzymes & Kits & Reagents Market?
5. Which modes and strategic moves are suitable for entering the Molecular Biology Enzymes & Kits & Reagents Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Molecular Biology Enzymes & Kits & Reagents Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of genome projects across the world
5.1.1.2. Growing incidences of genetic disorders, metabolic diseases, and immune system disorders
5.1.1.3. Rise in use of bioinformatics and computational tools for genome analysis and drug discoveries.
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for genetic testing
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in molecular biology enzymes & kits & reagents
5.1.3.2. Expansion of molecular biology enzymes & kits & reagents in agriculture biotechnology
5.1.4. Challenges
5.1.4.1. Absence of high-end technology for storing genetic information
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Molecular Biology Enzymes & Kits & Reagents Market, by Type
6.1. Introduction
6.2. Enzymes
6.3.1. DNA Polymerases
6.3.2. Ligases
6.3.3. Restriction Enzymes
6.3. Kits
6.4.1. DNA Sequencing Kits
6.4.2. PCR Kits
6.4.3. RNA Extraction Kits
6.4. Reagents
6.5.1. Buffers
6.5.2. Dyes
6.5.3. Nucleotides
6.5.4. Primers
6.5.5. Stains
7. Molecular Biology Enzymes & Kits & Reagents Market, by Application
7.1. Introduction
7.2. Drug Discovery & Development
7.3. Epigenetics
7.4. Polymerase Chain Reaction
7.5. Sequencing
8. Molecular Biology Enzymes & Kits & Reagents Market, by End-User
8.1. Introduction
8.2. Academic & Research institutions
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Pharma & Biotech Companies
9. Americas Molecular Biology Enzymes & Kits & Reagents Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Molecular Biology Enzymes & Kits & Reagents Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Molecular Biology Enzymes & Kits & Reagents Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ACROBiosystems Inc.
13.1.2. Agilent Technologies, Inc.
13.1.3. Bio Basic Inc.
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. F. Hoffmann-La Roche Ltd.
13.1.6. Fortis Life Sciences
13.1.7. Illumina, Inc.
13.1.8. Jena Bioscience GmbH
13.1.9. Krishgen Biosystems
13.1.10. LGC Limited
13.1.11. Merck KGaA
13.1.12. Miltenyi Biotec B.V. & Co. KG
13.1.13. Molecular Biology Resources, Inc.
13.1.14. New England Biolabs, Inc.
13.1.15. PerkinElmer Inc.
13.1.16. Promega Corporation
13.1.17. QIAGEN N.V.
13.1.18. Rockland Immunochemicals, Inc.
13.1.19. Sartorius AG
13.1.20. Takara Holdings Inc.
13.1.21. Thermo Fisher Scientific Inc.
13.1.22. Zymo Research Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET RESEARCH PROCESS
FIGURE 2. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET DYNAMICS
FIGURE 7. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. MOLECULAR BIOLOGY ENZYMES & KITS & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings